RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma model

Molecular Cancer Therapeutics · Published 2026-06-25 · DOI 10.1158/1535-7163.mct-25-1295

Authors (20)

Charlotte Marx, Julia Teppert, Laura Marisch, Simone Formisano, Anne Senz, Daniel F.R. Boehmer, Philipp Metzger, Daryna Kechur, Luisa Delius, Christine Hoerth, Kirsten Lauber, Doris Mayr, Enrico N. De Toni, Mike W. Helms, Bodo Brunner, Stefan Endres, Max Schnurr, Peter Duewell, Simon Rothenfusser, Lars M. Koenig

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Marx, C., Teppert, J., Marisch, L., et al. (2026). RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma model. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-25-1295

Related articles